Founded in 2020 with a total investment of 150 million RMB and located in West China Health Valley, Chengdu, Sichuan, SunGene&Cell is a biotechnology innovation enterprise dominated by cell technology with a core focus on clinical R&D and regenerative health.
Supported by a powerful "biomedical space" and the introduced high-level talents with master's and doctoral degrees from the Regenerative Medicine Research Center of West China Hospital, SunGene&Cell is deeply engaged in the translational application research of stem cell, immune cell and exosome technologies, and committed to building a safe, accurate and systematic transformation center of bioscience innovation services, with the corporate philosophy of "integrate innovation, win-win cooperation”.
The biomedical space has a total area of about 2,000 square meters, and its main functions include cell production area, cell drug research and development center, quality research area, as well as sample water station, UPS power distribution room, smoke exhaust machine room, and sewage treatment station that meet GMP requirements. At present, more than 50 million yuan has been invested, and it is equipped with domestic first-class research and development equipment for stem cell therapy, immune cell therapy and exosome drugs, including multiple sets of bioreactors, program-controlled cooling devices, high-resolution mass spectrometry, single-cell sequencers, complete Automatic blood bacterial culture instrument, flow cytometer, UPLC/HPLC and other imported equipment. Build differentiated technology platforms and R&D pipelines in the fields of wound repair, cell sequencing, and immune regulation.
Bring cell therapy to thousands of households
Precisely control cell quality and reshape healthy life
Integrate innovation, win-win cooperation